|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Ankit Jain (Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, Texas, USA) , Nishit Mody, PhD (Department of Pharmaceutical Science, Dr. Hari Singh Gour University, Sagar, Madhya Pradesh, India) , Srinath Palakurthi, PhD. (Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, Texas, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Weight: 0.450kg ISBN: 9780443291258ISBN 10: 044329125 Pages: 456 Publication Date: 18 June 2025 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of Contents1. Anomalous tumour microenvironment: exploitable features for drug delivery 2. Vesicular carriers for stimuli-responsive drug delivery to tumours: design considerations 3. Role of dePEGylation in vesicular carriers mediated stimuli-responsive drug delivery to tumours 4. pH-responsive vesicular carriers as promising tools for tumour targeting 5. Enzyme-responsive vesicular carriers as an emerging approach for tumour targeting 6. Redox-responsive vesicular carriers for potential tumour-targeting applications 7. Hypoxia-responsive vesicular carriers for enhanced tumour targeting 8. Magnetically responsive and thermo-responsive vesicular carriers for improved drug delivery to tumours 9. Ultrasound-responsive vesicular carriers for tumour targeting 10. Light-triggered vesicular carriers for tumour targeting 11. Electro- and Mechano-responsive vesicular carriers targeting tumours 12. Emerging applications of stimuli-responsive novel vesicular carriers: Exosomes, supramolecular vesicles, and catanionic vesicles 13. Vesicular carriers with multipronged features for diagnostics and theranostics 14. Nanotoxicity and challenges in stimuli-responsive vesicular carriers targeting tumour 15. Patents, clinical trials, and regulatory concerns with stimuli-responsive vesicular carriers.ReviewsAuthor InformationDr. Ankit Jain is currently working as a Postdoctoral Research Associate at Texas A&M University School of Pharmacy, Texas. He completed his B. Pharm. (2006-09), M. Pharm. (Pharmaceutics, 2009-11), and Ph.D. (2012-17). Dr. Jain has been exploring different vesicular carriers viz. liposomes, niosomes, and micelles for the last eleven years. He has earmarked an appreciation for his outstanding performance in academics. He has been conferred with the “MP Young Scientist Award- 2017. He has published 60 International publications in journals of high repute (Citations = 2500+, h-index = 21, and I10-index = 55) along with 25 book chapters in International Books. He is a reviewer and editorial board member of different renowned journals of international publishers An overarching goal of his current research is the development of nano-engineered drug delivery systems for various diseases with a prime focus on cancer Dr. Nishi Mody is presently working as a Guest Lecturer in the Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar (M.P). She possesses a Gold Medal in B. Pharm. and M. Pharm and was awarded DST-INSPIRE for her Ph.D. She has a good number of publications (22) published in peer-reviewed International Journals with high impact factors (Biotechnology Advances, Nanomedicine, etc.) and many book chapters (23) in international books. She has been awarded many prestigious awards including M.P. Young Scientist Award-2020, the Pharmaceutical Science Alumni Award consecutively for two years (2007 and 2008), Prof. C. S. Chauhan Gold Medal (2009), IDMA J.B. Mody Award (2009) and Nagarjuna Award (2011) for her excellent academic performance in U.G. and P.G. programs... Her area of research is focused on nanofabrications of polymeric and vesicular systems for cancer treatment with recent advances in the state-of-art of her domain Prof. Srinath Palakurthi is a Professor at Irma Lerma Rangel School of Pharmacy at Texas A&M University, Kingsville, Texas. He has a strong background in drug delivery and pharmacokinetics with expertise in particulate and vesicular carrier systems for targeted drug and gene delivery applications. His research group has been working on different targeted drug delivery systems for cancer with a focus on combination therapy. He is the recipient of many prestigious awards including President’s Excellence Research Fund, Texas A& M University (2018), Academic Research Fellow, American Association of Colleges of Pharmacy (AACP) (2015), Governor’s 2010 Initiative (2005-2010), Research Centres Program, SD (2010), Governor’s 2010 Individual Research Seed Grant, SD (2005). Professor Palakurthi has a good number of publications in journals of high international repute. Tab Content 6Author Website:Countries AvailableAll regions |